Biogennix

12 articles about Biogennix

• Biogennix Launches OsteoSPAN Fiber Matrix

  10/24/2023

  Irvine-based Biogennix, an osteobiologics company that develops, manufactures, and distributes proprietary bone graft products used for bone fusion procedures, announced the launch of its new OsteoSPAN Fiber Matrix.

• Biogennix’s DirectCell Advanced Bone Grafting System Used in 500th Case

  5/17/2022

  Irvine-based Biogennix, a market leader in advanced bone regeneration technology, announced that its DirectCell Advanced Bone Grafting System has already been used in over 500 cases.

• Biogennix Receives FDA Clearance for Expanded Use of Agilon Moldable Bone Grafting Solution in Spine Procedures

  3/4/2020

  Irvine-based Biogennix, an osteobiologics company that develops, manufactures, and distributes proprietary bone graft products used for bone fusion procedures, today announced that it has received U.S. Food and Drug Administration (FDA) 510(k) clearance for an expanded indication for its AgilonTM moldable bone grafting product.

• Biogennix Teams with Second Harvest Food Bank to Give Back to the Community

  11/14/2019

  The company and its employees chose to donate a Wednesday afternoon supporting Second Harvest Food Bank of Orange County.

• Biogennix Exhibits TrelCor Technology at North American Spine Society Meeting

  10/2/2019

  Irvine-based Biogennix, an osteobiologics company that develops, manufactures, and distributes proprietary bone graft products used for bone fusion procedures, exhibited its TrelCor™ technology at the North American Spine Society annual meeting last week, including its newest product, Agilon™, which was recently cleared by the FDA for use in bone fusions.

• Biogennix Reports Record Sales Month for July

  8/13/2019

  Irvine-based Biogennix, an osteobiologics company that develops, manufactures, and distributes proprietary bone grafting products used for bone fusion procedures, announced today that its July performance was the best in the company’s history.

• Orange County Osteobiologics Company Gives Back to the Planet with Beach Cleanup

  4/22/2019

  Biogennix, an osteobiologics company that develops, manufactures, and distributes proprietary bone graft substitutes used for bone fusion procedures spent the morning at the beach last Friday – but it was not a surfing or sunbathing expedition.

• Biogennix Names Michael Roux General Manager

  1/8/2019

  Company Also Expands Sales, Marketing and R&D Teams

• Biogennix Reports Additional 33% Growth in Q1

  5/15/2018

  Biogennix announced today that it saw 33% growth for the first quarter of 2018.

• Biogennix Reports Record Growth for 2017; Expands Executive Management Team

  1/17/2018

  The company closed the year with 47% growth, the broadest increase the company has experienced in its history.

• Biogennix Ramps Up National Distribution for Bone Graft Substitute Products osteoSPAN and Morpheus

  10/25/2017

  Irvine-based Biogennix announced today that it is expanding its distribution efforts for its novel bone graft substitutes, Morpheus and osteoSPAN to full national distribution.

• Biogennix Bone Graft Substitute Materials Used To Treat 6000th Patient

  9/21/2017